SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Prasad S Kulkarni, Sharad Agarkhedkar, Sanjay Lalwani, Ashish R Bavdekar, Sameer Jog, Sidram K Raut, Varsha Parulekar, Shalaka S Agarkhedkar, Sonali Palkar, Somnath Mangrule, Effectiveness of an Indian-made Attenuated influenza A(H1N1)pdm 2009 vaccine: A case control study, Human vaccines & immunotherapeutics, 2014, 10, 3, 566

    CrossRef

  2. 2
    T. Nolan, S. Roy-Ghanta, M. Montellano, L. Weckx, R. Ulloa-Gutierrez, E. Lazcano-Ponce, A. Kerdpanich, M. A. P. Safadi, A. Cruz-Valdez, S. Litao, F. S. Lim, A. M. de Los Santos, M. A. R. Weber, J.-C. Tinoco, M. H.-d. Mezerville, I. Faingezicht, P. Kosuwon, P. Lopez, C. Borja-Tabora, P. Li, S. Durviaux, L. Fries, G. Dubin, T. Breuer, B. L. Innis, D. W. Vaughn, Relative Efficacy of AS03-Adjuvanted Pandemic Influenza A(H1N1) Vaccine in Children: Results of a Controlled, Randomized Efficacy Trial, Journal of Infectious Diseases, 2014, 210, 4, 545

    CrossRef

  3. 3
    Christopher B Fox, Jean Haensler, An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants, Expert Review of Vaccines, 2013, 12, 7, 747

    CrossRef

  4. 4
    Staffan P.E Sylvan, Brith Christenson, Karlis Pauksen, Lars Berglund, Clinical and epidemiological findings in patients with pandemic A(H1N1) 2009 influenza in uppsala county, Sweden, Research Journal of Infectious Diseases, 2013, 1, 1, 6

    CrossRef

  5. You have full text access to this Open Access content5
    Paul G. Van Buynder, Gillian Frosst, Jan L. Van Buynder, Francios-William Tremblay, Alie Ross, Claire Jardine, Bao Gang Fei, Increased reactions to pediatric influenza vaccination following concomitant pneumococcal vaccination, Influenza and Other Respiratory Viruses, 2013, 7, 2
  6. 6
    William H. Yang, Marc Dionne, Michael Kyle, Naresh Aggarwal, Ping Li, Miguel Madariaga, Olivier Godeaux, David W. Vaughn, Long-term immunogenicity of an AS03-adjuvanted influenza A(H1N1)pdm09 vaccine in young and elderly adults: An observer-blind, randomized trial, Vaccine, 2013, 31, 40, 4389

    CrossRef

  7. 7
    P.G. Van Buynder, S. Konrad, J.L. Van Buynder, E. Brodkin, M. Krajden, G. Ramler, M. Bigham, The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine (TIV) in the elderly, Vaccine, 2013, 31, 51, 6122

    CrossRef

  8. 8
    Anthony E. Fiore, Carolyn B. Bridges, Jacqueline M. Katz, Nancy J. Cox, Vaccines, 2013,

    CrossRef

  9. 9
    Nathalie Garçon, David W Vaughn, Arnaud M Didierlaurent, Development and evaluation of AS03, an Adjuvant System containing α-tocopherol and squalene in an oil-in-water emulsion, Expert Review of Vaccines, 2012, 11, 3, 349

    CrossRef

  10. 10
    A. Uzicanin, M. Thompson, P. Smith, S. S. Chaves, L. Foster, N. Dube, S. Graitcer, R. Jackson, J. Ferdinands, P. Gargiullo, D. Mills, A. S. Monto, D. K. Shay, Effectiveness of 1 Dose of Influenza A (H1N1) 2009 Monovalent Vaccines in Preventing Reverse-Transcription Polymerase Chain Reaction-Confirmed H1N1 Infection Among School-Aged Children in Maine, Journal of Infectious Diseases, 2012, 206, 7, 1059

    CrossRef

  11. 11
    S. Jiménez-Jorge, C. Savulescu, F. Pozo, S. de Mateo, I. Casas, J. Ledesma, A. Larrauri, Effectiveness of the 2010–11 seasonal trivalent influenza vaccine in Spain: cycEVA study, Vaccine, 2012, 30, 24, 3595

    CrossRef

  12. 12
    Åke Örtqvist, Rutger Bennet, Malin Ryd Rinder, Hans Lindblad, Margareta Eriksson, Effectiveness of the monovalent AS03-adjuvanted influenza A(H1N1)pdm09 vaccine against hospitalization in children because of influenza, Vaccine, 2012, 30, 39, 5699

    CrossRef

  13. 13
    W. T. Walker, P. de Whalley, N. Andrews, C. Oeser, M. Casey, L. Michaelis, K. Hoschler, C. Harrill, P. Moulsdale, B. Thompson, C. Jones, J. Chalk, S. Kerridge, T. M. John, I. Okike, S. Ladhani, R. Tomlinson, P. T. Heath, E. Miller, S. N. Faust, M. D. Snape, A. Finn, A. J. Pollard, H1N1 Antibody Persistence 1 Year After Immunization With an Adjuvanted or Whole-Virion Pandemic Vaccine and Immunogenicity and Reactogenicity of Subsequent Seasonal Influenza Vaccine: A Multicenter Follow-on Study, Clinical Infectious Diseases, 2012, 54, 5, 661

    CrossRef

  14. 14
    Jiehui Kevin Yin, Maria Yui Kwan Chow, Gulam Khandaker, Catherine King, Peter Richmond, Leon Heron, Robert Booy, Impacts on influenza A(H1N1)pdm09 infection from cross-protection of seasonal trivalent influenza vaccines and A(H1N1)pdm09 vaccines: Systematic review and meta-analyses, Vaccine, 2012, 30, 21, 3209

    CrossRef

  15. 15
    Wiebke Hellenbrand, Pernille Jorgensen, Brunhilde Schweiger, Gerhard Falkenhorst, Matthias Nachtnebel, Benedikt Greutélaers, Christian Traeder, Ole Wichmann, Prospective hospital-based case–control study to assess the effectiveness of pandemic influenza A(H1N1)pdm09 vaccination and risk factors for hospitalization in 2009–2010 using matched hospital and test-negative controls, BMC Infectious Diseases, 2012, 12, 1, 127

    CrossRef

  16. 16
    Joanne M. Langley, Dennis Reich, Naresh Aggarwal, David Connor, Marc H. Lebel, Anil Gupta, Hartley Garfield, Ping Li, Anu Madan, David W. Vaughn, Randomized, Multicenter Trial of a Single Dose of AS03-adjuvanted or Unadjuvanted H1N1 2009 Pandemic Influenza Vaccine in Children 6 Months to <9 Years of Age, The Pediatric Infectious Disease Journal, 2012, 31, 8, 848

    CrossRef

  17. 17
    Joanne M. Langley, David W. Scheifele, Caroline Quach, Otto G. Vanderkooi, Brian Ward, Shelly McNeil, Simon Dobson, James D. Kellner, Susan Kuhn, Tobias Kollman, Donna MacKinnon-Cameron, Bruce Smith, Yan Li, Scott A. Halperin, Safety and immunogenicity of 2010–2011 H1N12009-containing trivalent inactivated influenza vaccine in children 12–59 months of age previously given AS03-adjuvanted H1N12009 pandemic vaccine: A PHAC/CIHR Influenza Research Network (PCIRN) study, Vaccine, 2012, 30, 23, 3389

    CrossRef

  18. 18
    Akihiko Saitoh, Akira Nagai, Kazuyoshi Tenjinbaru, Ping Li, François Roman, Tatsuo Kato, Safety and persistence of immunological response 6 months after intramuscular vaccination with an AS03-adjuvanted H1N1 2009 influenza vaccine: An open-label, randomized trial in Japanese children aged 6 months to 17 years, Human vaccines & immunotherapeutics, 2012, 8, 6, 749

    CrossRef

  19. 19
    Woolf T Walker, Saul N Faust, Emulsion-based Vaccine Adjuvants, 2012,

    CrossRef

  20. 20
    Vladimir Gilca, Gaston De Serres, Marie-Eve Hamelin, Guy Boivin, Manale Ouakki, Nicole Boulianne, Chantal Sauvageau, Marc Dionne, Rodica Gilca, Danuta Skowronski, Antibody persistence and response to 2010–2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children, Vaccine, 2011, 30, 1, 35

    CrossRef

  21. 21
    A. Ortqvist, I. Berggren, M. Insulander, B. de Jong, B. Svenungsson, Effectiveness of an Adjuvanted Monovalent Vaccine Against the 2009 Pandemic Strain of Influenza A(H1N1)v in Stockholm County, Sweden, Clinical Infectious Diseases, 2011, 52, 10, 1203

    CrossRef

  22. 22
    Salaheddin Mahmud, Gregory Hammond, Lawrence Elliott, Tim Hilderman, Carol Kurbis, Patricia Caetano, Paul Van Caeseele, Joel Kettner, Magdy Dawood, Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: Population-based case–control study, Vaccine, 2011, 29, 45, 7975

    CrossRef

  23. 23
    J. Garcia-Sicilia, P. Gillard, A. Carmona, J.C. Tejedor, J. Aristegui, J.M. Merino, U. Behre, A. Caplanusi, T. Vaman, I. Dieussaert, Immunogenicity and safety of AS03-adjuvanted H1N1 pandemic vaccines in children and adolescents, Vaccine, 2011, 29, 26, 4353

    CrossRef

  24. 24
    Marc P. Girard, Jacqueline M. Katz, Yuri Pervikov, Joachim Hombach, John S. Tam, Report of the 7th meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials, World Health Organization, Geneva, 17–18 February 2011, Vaccine, 2011, 29, 44, 7579

    CrossRef

  25. 25
    Beate Sander, Response to Rolland-Harris, Vaccine, 2011, 29, 22, 3830

    CrossRef

  26. 26
    Heath A Kelly, Patricia C Priest, Geoffry N Mercer, Gary K Dowse, We should not be complacent about our population-based public health response to the first influenza pandemic of the 21st century, BMC Public Health, 2011, 11, 1, 78

    CrossRef

  27. 27
    Woolf T Walker, Saul N Faust, Monovalent inactivated split-virion AS03-adjuvanted pandemic influenza A (H1N1) vaccine, Expert Review of Vaccines, 2010, 9, 12, 1385

    CrossRef

  28. 28
    Tom Jefferson, Alessandro Rivetti, Carlo Di Pietrantonj, Vittorio Demicheli, Eliana Ferroni, Vaccines for preventing influenza in healthy children, The Cochrane Library,